Novo CEO pressed by Senate to cut selling prices of being overweight, diabetes medicines CEO Lars Fruergaard Jørgensen told lawmakers the business would contemplate new talks with insurers with regards to the checklist prices of Wegovy and copyright should they pledge to maintain the medicines on their own formularies. Elevance https://martinukarh.suomiblog.com/healthcare-news-an-overview-46313208